News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agenix Limited Showcase Promising New Low-Risk Hepatitis Drug for China Market at Bio Korea 2011



10/3/2011 11:16:06 AM

Sydney, Sep 30, 2011 (ABN Newswire) - Agenix Limited (ASX:AGX) confirmed its promising new hepatitis B drug, AGX-1009, shared the same active compound as Gilead's (NASDAQ:GILD) blockbuster drug, Viread, which is widely used to treat HIV and hepatitis throughout Asia.

Read at ABN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES